Eton Pharmaceuticals, Inc. ETON Increlex — Contract With Customer Liability Current
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s increlex — contract with customer liability current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s increlex — contract with customer liability current?
- Eton Pharmaceuticals, Inc. (ETON) reported increlex — contract with customer liability current of $457K in Q1 2026.
- What does increlex — contract with customer liability current mean?
- The portion of the total contract liability for Increlex that is expected to be satisfied or recognized as revenue within the next twelve months. This metric provides insight into the short-term performance obligations and the expected timing of revenue realization. It is a critical component for assessing near-term cash flow and operational commitments.